161 related articles for article (PubMed ID: 38529348)
1. COPD: systemic proteomic profiles in frequent and infrequent exacerbators.
Enríquez-Rodríguez CJ; Casadevall C; Faner R; Castro-Costa A; Pascual-Guàrdia S; Seijó L; López-Campos JL; Peces-Barba G; Monsó E; Barreiro E; Cosío BG; Agustí A; Gea J;
ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38529348
[TBL] [Abstract][Full Text] [Related]
2. Identification of proteomic signatures associated with COPD frequent exacerbators.
Sun P; Ye R; Wang C; Bai S; Zhao L
Life Sci; 2019 Aug; 230():1-9. PubMed ID: 31121174
[TBL] [Abstract][Full Text] [Related]
3. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
[TBL] [Abstract][Full Text] [Related]
4. Monocyte related haematological indices in acute exacerbations of COPD - a new biomarker?
Dukić V; Muršić D; Popović Grle S; Jakopović M; Ružić A; Vukić Dugac A
Monaldi Arch Chest Dis; 2023 Sep; ():. PubMed ID: 37753773
[TBL] [Abstract][Full Text] [Related]
5. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
Li W; Wang B; Tan M; Song X; Xie S; Wang C
Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
[TBL] [Abstract][Full Text] [Related]
6. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
7. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population.
Dalal AA; Patel J; D'Souza A; Farrelly E; Nagar S; Shah M
J Manag Care Spec Pharm; 2015 Jul; 21(7):575-83. PubMed ID: 26108382
[TBL] [Abstract][Full Text] [Related]
8. Alveolar Nitric Oxide and Peripheral Oxygen Saturation in Frequent Exacerbators with Asthma: A Pilot Study.
Sprio AE; Bertolini F; Fucà R; Levra S; Carriero V; Högman M; Ricciardolo FLM
Int Arch Allergy Immunol; 2022; 183(1):105-115. PubMed ID: 34515153
[TBL] [Abstract][Full Text] [Related]
9. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
[TBL] [Abstract][Full Text] [Related]
11. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
12. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
13. Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.
Houston CJ; Alkhatib A; Einarsson GG; Tunney MM; Taggart CC; Downey DG
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38135443
[TBL] [Abstract][Full Text] [Related]
14. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.
Dang X; Kang Y; Wang X; Cao W; Li M; He Y; Pan X; Ye K; Xu D
Front Microbiol; 2022; 13():1037037. PubMed ID: 36532417
[TBL] [Abstract][Full Text] [Related]
15. No association between exacerbation frequency and stroke in patients with COPD.
Windsor C; Herrett E; Smeeth L; Quint JK
Int J Chron Obstruct Pulmon Dis; 2016; 11():217-25. PubMed ID: 26893553
[TBL] [Abstract][Full Text] [Related]
16. Real-Time Breath Analysis Reveals Specific Metabolic Signatures of COPD Exacerbations.
Gaugg MT; Nussbaumer-Ochsner Y; Bregy L; Engler A; Stebler N; Gaisl T; Bruderer T; Nowak N; Sinues P; Zenobi R; Kohler M
Chest; 2019 Aug; 156(2):269-276. PubMed ID: 30685334
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD.
Liu X; Qu J; Xue W; He L; Wang J; Xi X; Liu X; Yin Y; Qu Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():1217-1228. PubMed ID: 29713155
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of roflumilast in the COPD frequent exacerbator phenotype.
Wedzicha JA; Rabe KF; Martinez FJ; Bredenbröker D; Brose M; Goehring UM; Calverley PMA
Chest; 2013 May; 143(5):1302-1311. PubMed ID: 23117188
[TBL] [Abstract][Full Text] [Related]
19. Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.
Scioscia G; Blanco I; Arismendi E; Burgos F; Gistau C; Foschino Barbaro MP; Celli B; O'Donnell DE; Agustí A
Thorax; 2017 Feb; 72(2):117-121. PubMed ID: 27586869
[TBL] [Abstract][Full Text] [Related]
20. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
Fortis S; Wan ES; Kunisaki K; Eyck PT; Ballas ZK; Bowler RP; Crapo JD; Hokanson JE; Wendt C; Silverman EK; Comellas AP
Respir Med X; 2021 Nov; 3():. PubMed ID: 35911870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
